Periodontal Care and Glycemic Control in Diabetes
Poor Glycemic Control
Drug: Doxycycline HCI 10mg po for 2 weeks
Procedure: Ultrasonic scaling with 0.12% chlorhexidine gluconate
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Single Blind
Primary Purpose: Treatment
|Official Title:||Periodontal Care and Glycemic Control in Diabetes|
|Study Completion Date:||September 2003|
|Arm 1||Drug: Doxycycline HCI 10mg po for 2 weeks Procedure: Ultrasonic scaling with 0.12% chlorhexidine gluconate|
Diabetes is a prevalent and costly disease among users of VA care. Goals of diabetes care include the prevention and/or delay of complications via adequate glycemic control. Improvements in periodontal status may also improve diabetes control.
This project will determine the efficacy of a program of periodontal screening and therapy in improving the level of glycemic control in poorly controlled diabetics.
Subject accrual is complete. Data collection is ongoing.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00012688
|United States, Massachusetts|
|Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA|
|Bedford, Massachusetts, United States, 01730|
|Principal Investigator:||Judith A. Jones, DDS DSc MPH||Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA|